BATON ROUGE - Two Louisiana residents reported separate cases of severe illness following counterfeit Botox injections, leading the Louisiana Department of Health to issue a warning about taking proper precautions.
The LDH said o ne patient received injections of an unlicensed botulinum toxin product purchased online, and one patient received injections from an individual with unknown licensure in a non-medical setting. The two began experiencing botulism-like symptoms a few days following the injections.
Both experienced severe illness requiring hospitalization.
The LDH reminded people to make sure their product is sourced from an FDA-approved, licensed supplier and provider. Additionally, people are told to only get injections in a licensed or accredited healthcare setting and to not